Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Waldenstrom Macroglobulinemia × Celecoxib × Clear all

Sponsor

Conditions

Colorectal Neoplasms 9 Breast Neoplasms 9 Colonic Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Rectal Neoplasms 4 Lung Neoplasms 4 Head and Neck Neoplasms 4 Adenomatous Polyposis Coli 4 Sarcoma 3 Glioblastoma 3 Central Nervous System Neoplasms 3 Paranasal Sinus Neoplasms 2 Neoplasms 2 Mouth Neoplasms 2 Melanoma 2 Laryngeal Neoplasms 2 Gliosarcoma 2 Breast Carcinoma In Situ 2 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Triple Negative Breast Neoplasms 1 Tobacco Use Disorder 1 Stomatitis 1 Smoldering Multiple Myeloma 1 Smoking 1 Recurrence 1 Prostatic Neoplasms 1 Prostatic Hyperplasia 1 Precancerous Conditions 1

Interventions

Rituximab 49 fludarabine phosphate 32 Cyclophosphamide 29 Whole-Body Irradiation 26 Peripheral Blood Stem Cell Transplantation 25 Mycophenolic Acid 23 Tacrolimus 19 Cyclosporine 15 Dexamethasone 13 Busulfan 13 ibrutinib 12 Sirolimus 11 Bortezomib 11 Antilymphocyte Serum 11 Melphalan 10 Etoposide 10 Calcium Dobesilate 10 Methotrexate 8 Lenalidomide 8 idelalisib 7 Cyclosporins 7 Everolimus 6 Indium 5 Filgrastim 5 thymoglobulin 4 ibritumomab tiuxetan 4 carfilzomib 4 Vincristine 4 Prednisone 4 In Situ Hybridization, Fluorescence 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡